Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a post by ECOG-ACRIN Cancer Research Group, on X/Twitter, adding:
”Excited to present results of this trial focused solely on Black people with breast cancer at ASCO24 adjuvant breast session. Â
Picture below highlights patient recruitment efforts developed with advocate extraordinaire Lisa Hayes.”
Quoting ECOG-ACRIN Cancer Research Group’s post:
”Results of ECOG-ACRIN Cancer Research Group EAZ171 prospective validation of germline variants and taxane type in associated with taxane-induced peripheral neuropathy in Black women with early breast cancer at ASCO24 by Tarah Ballinger, IU Simon Comprehensive Cancer Center.
Monday 6/3, 3PM CT, Hall B1+livestream LBA503.”
Read further.
Source: Tarah Ballinger/X and ECOG-ACRIN Cancer Research Group/X